Tscan Therapeutics Inc (TCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 4,056 | 3,021 | 2,854 | 2,412 | 2,848 |
| Gross Profit | 4,056 | 3,021 | 2,854 | 2,412 | 2,848 |
| Operating Expenses | 19,302 | 19,184 | 17,056 | 18,254 | 13,527 |
| Operating Income | -15,246 | -16,163 | -14,202 | -15,842 | -10,679 |
| Other Income | 149 | 7 | 2 | 3 | 5 |
| Pre-tax Income | -15,097 | -16,156 | -14,200 | -15,839 | -10,674 |
| Net Income Continuous | -15,097 | -16,156 | -14,200 | -15,839 | -10,674 |
| Net Income | $-15,097 | $-16,156 | $-14,200 | $-15,839 | $-10,674 |
| EPS Basic Total Ops | -0.63 | -0.67 | 10.81 | -0.80 | -7.69 |
| EPS Basic Continuous Ops | -0.63 | -0.67 | 10.81 | -0.80 | -7.69 |
| EPS Diluted Total Ops | -0.63 | -0.67 | 10.81 | -0.80 | -7.69 |
| EPS Diluted Continuous Ops | -0.63 | -0.67 | 10.81 | -0.80 | -7.69 |
| EBITDA(a) | $-14,039 | $-14,968 | $-13,060 | $-14,786 | $-10,018 |